The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.
The increasing complexity and diversity of the human immunodeficiency virus-1 (HIV-1) infections challenge the disease control and anti-retrovirus treatment in China. The infection stages and molecular characteristics of HIV-1 from infected Chinese blood donors were examined to shed light on the HIV...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179328&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850231107467870208 |
|---|---|
| author | Peibin Zeng Yu Liu Miao He Jingxing Wang Sheila Keating Wei Mao Mei Huang Hongli Ma Weilan He Xinhong Bi Dan Liao Michael Busch Paul Ness Jing Liu Hua Shan NHLBI Recipient Epidemiology and Donor Evaluation Study-III program |
| author_facet | Peibin Zeng Yu Liu Miao He Jingxing Wang Sheila Keating Wei Mao Mei Huang Hongli Ma Weilan He Xinhong Bi Dan Liao Michael Busch Paul Ness Jing Liu Hua Shan NHLBI Recipient Epidemiology and Donor Evaluation Study-III program |
| author_sort | Peibin Zeng |
| collection | DOAJ |
| description | The increasing complexity and diversity of the human immunodeficiency virus-1 (HIV-1) infections challenge the disease control and anti-retrovirus treatment in China. The infection stages and molecular characteristics of HIV-1 from infected Chinese blood donors were examined to shed light on the HIV genotype distribution and the status of drug resistance mutations (DRMs) in the changing HIV epidemic in China. Western blot (WB) confirmed HIV-1 positive plasma samples were collected from blood donors at five Chinese blood centers from April 16, 2012, through June 30, 2014. The HIV infection stages were determined using the Lag-avidity assay. HIV Pol regions including whole protease and partial reverse transcriptase (RT) were amplified and sequenced to establish the profile of genotype distribution and drug resistance mutations (DRMs). Viral loads were determined using the ROCHE COBAS system. Of the 259 HIV-1 positive samples tested by the Lag-avidity assay, 23.6% (61/259) were identified as recent infections. A total of 205 amplified sequences displayed the following genotype distributions: circulating recombinant form (CRF) 07_BC (61.5%), CRF08_BC (8.3%), CRF01_AE (20%), B (6.3%), and 01B (3.9%). There was no significant difference in genotype distribution between recent and long-term infections. 31 DRMs were identified from 27 samples including four protease inhibitors (PIs) accessory DRMs, two PIs major DRMs (M46I), two nucleoside RT inhibitors DRMs (K219R and K70Q), and 23 nonnucleoside RT inhibitors DRMs. 27 samples had DRMs, yielding a drug resistance prevalence of 13.2% (27/205). Our findings provide important information for developing strategies for comprehensive HIV control and improving anti-retroviral treatment in China. |
| format | Article |
| id | doaj-art-c488f874354f43399a2cff93ea8fa825 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c488f874354f43399a2cff93ea8fa8252025-08-20T02:03:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017932810.1371/journal.pone.0179328The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.Peibin ZengYu LiuMiao HeJingxing WangSheila KeatingWei MaoMei HuangHongli MaWeilan HeXinhong BiDan LiaoMichael BuschPaul NessJing LiuHua ShanNHLBI Recipient Epidemiology and Donor Evaluation Study-III programThe increasing complexity and diversity of the human immunodeficiency virus-1 (HIV-1) infections challenge the disease control and anti-retrovirus treatment in China. The infection stages and molecular characteristics of HIV-1 from infected Chinese blood donors were examined to shed light on the HIV genotype distribution and the status of drug resistance mutations (DRMs) in the changing HIV epidemic in China. Western blot (WB) confirmed HIV-1 positive plasma samples were collected from blood donors at five Chinese blood centers from April 16, 2012, through June 30, 2014. The HIV infection stages were determined using the Lag-avidity assay. HIV Pol regions including whole protease and partial reverse transcriptase (RT) were amplified and sequenced to establish the profile of genotype distribution and drug resistance mutations (DRMs). Viral loads were determined using the ROCHE COBAS system. Of the 259 HIV-1 positive samples tested by the Lag-avidity assay, 23.6% (61/259) were identified as recent infections. A total of 205 amplified sequences displayed the following genotype distributions: circulating recombinant form (CRF) 07_BC (61.5%), CRF08_BC (8.3%), CRF01_AE (20%), B (6.3%), and 01B (3.9%). There was no significant difference in genotype distribution between recent and long-term infections. 31 DRMs were identified from 27 samples including four protease inhibitors (PIs) accessory DRMs, two PIs major DRMs (M46I), two nucleoside RT inhibitors DRMs (K219R and K70Q), and 23 nonnucleoside RT inhibitors DRMs. 27 samples had DRMs, yielding a drug resistance prevalence of 13.2% (27/205). Our findings provide important information for developing strategies for comprehensive HIV control and improving anti-retroviral treatment in China.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179328&type=printable |
| spellingShingle | Peibin Zeng Yu Liu Miao He Jingxing Wang Sheila Keating Wei Mao Mei Huang Hongli Ma Weilan He Xinhong Bi Dan Liao Michael Busch Paul Ness Jing Liu Hua Shan NHLBI Recipient Epidemiology and Donor Evaluation Study-III program The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. PLoS ONE |
| title | The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
| title_full | The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
| title_fullStr | The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
| title_full_unstemmed | The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
| title_short | The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014. |
| title_sort | infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus 1 infected blood donors from five chinese blood centers 2012 2014 |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179328&type=printable |
| work_keys_str_mv | AT peibinzeng theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT yuliu theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT miaohe theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT jingxingwang theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT sheilakeating theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT weimao theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT meihuang theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT honglima theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT weilanhe theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT xinhongbi theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT danliao theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT michaelbusch theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT paulness theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT jingliu theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT huashan theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT nhlbirecipientepidemiologyanddonorevaluationstudyiiiprogram theinfectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT peibinzeng infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT yuliu infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT miaohe infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT jingxingwang infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT sheilakeating infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT weimao infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT meihuang infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT honglima infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT weilanhe infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT xinhongbi infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT danliao infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT michaelbusch infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT paulness infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT jingliu infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT huashan infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 AT nhlbirecipientepidemiologyanddonorevaluationstudyiiiprogram infectionstagingandprofileofgenotypicdistributionanddrugresistancemutationamongthehumanimmunodeficiencyvirus1infectedblooddonorsfromfivechinesebloodcenters20122014 |